Objective The COVID-19 pandemic is a biosecurity threat, and many resource-rich countries
are stockpiling and/or making plans to secure supplies of vaccine, therapeutics, and …

Africa's health systems are strained by the COVID-19 pandemic. There are global efforts
toward the development and trial of COVID-19 vaccines. However, considering the …

Development COVID-19 vaccines in a record time has been an unprecedented global
scientific achievement. However, the world has failed to ensure equitable access to what …

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
resulted in a global pandemic, prompting unprecedented efforts to contain the virus. Many …

The COVID-19 pandemic triggered a sense of vulnerability and urgency that led to
concerted actions by governments, funders, regulators and industry to overcome traditional …

Following the development of the coronavirus disease 2019 (COVID-19) vaccines and the
launching of vaccination, the World Health Organization has reported that the African …

Nationalism has trumped solidarity, resulting in unnecessary loss of life and inequitable
access to vaccines and therapeutics. Existing intellectual property (IP) regimens, trade …

There is much ongoing debate and concern regarding access to COVID-19 vaccines and
roll-out gaps in low-income and middle-income countries compared with high-income …

COVID-19 vaccines: how to ensure Africa has access Skip to main content Thank you for
visiting nature.com. You are using a browser version with limited support for CSS. To obtain the …

South Africa became one of the first African countries to receive the COVID-19 vaccine. As
the rest of Africa prepares to receive COVID-19 vaccines, most countries in Africa have set …